Blood :: FDA Licenses 15 New Blood Typing Tests
The U.S. Food and Drug Administration licensed 15 new blood typing tests that were previously unavailable in the United States.
The U.S. Food and Drug Administration licensed 15 new blood typing tests that were previously unavailable in the United States.
GlaxoSmithKline (GSK) and Sepracor Inc. (Nasdaq: SEPR) announced an agreement for the commercialisation of Sepracor’s eszopiclone product for all markets worldwide (excluding the U.S., Canada, Mexico and Japan).
More than 20 million adults in the United States are living with diabetes and are at increased risk of cardiovascular disease (CVD). But there are steps that they can take to reduce the complications associated with these two diseases.
GlaxoSmithKline announced new results from a large study that demonstrate combination treatment with Avodart® (dutasteride) and the alpha blocker, tamsulosin, provides significantly greater urinary symptom improvement for men with enlarged prostate than either Avodart or tamsulosin monotherapy over 24 months.
The presence of mercury in dental amalgams, or fillings, is relatively common knowledge; however, whether its presence affects the neurological system is a debate that has been ongoing for 150 years.
The University of Rochester Medical Center (URMC) is participating in a multi-center study of a new medical device to treat epilepsy. The Rochester study is being overseen by neurologists Michel Berg, M.D. and James Fessler, M.D., and neurosurgeons Web Pilcher, M.D., Ph.D. and Jason Schwalb, M.D.
International humanitarian agencies have agreed on a new set of guidelines to address the mental health and psychosocial needs of survivors as part of the response to conflict or disaster.
A child born in the United States in 2005 can expect to live nearly 78 years (77.9) – a new high – according to a report released today by the Centers for Disease Control and Prevention, “Deaths: Preliminary Data for 2005.”
Feelings of social isolation are linked to alterations in the activity of genes that drive inflammation, the first response of the immune system, and causing higher mortality than people who are not feeling loneliness, revealed by UCLA researchers.
University of Iowa researchers investigating the basic biology of cell signaling have made a discovery that may have therapeutic implications for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases.